Search This Blog

Thursday, August 8, 2019

Magenta Therapeutics EPS beats by $0.05

Magenta Therapeutics (NASDAQ:MGTA): Q2 GAAP EPS of -$0.48 beats by $0.05.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)